Ncardia

Leiden, Netherlands · Founded 2010 · Privately Held (backing)

Operator of a biotechnology company intended to provide technologies to expedite drug discovery and development processes. Ncardia is based in Leiden, Netherlands and was founded in 2010. Its last known valuation is $174 million. It has raised $130 million.

Last price · $/share
—
Implied valuation
$174.0M
Total raised
$129.7M
Last round
—

Who backs Ncardia?

12 investors
InvestorType
NoshaqOther
InnovationQuarterOther
SambrInvestOther
Federal Holding and Investment Company (Brussels)Other
Société Régionale d'Investissement de WallonieOther
Epimède—
Health ~ Holland—
Kiniciti—
Mibiton—
Sino-German High Tech Fund—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ncardia investors

12 investors are on record for Ncardia, including Noshaq, InnovationQuarter, SambrInvest and Federal Holding and Investment Company (Brussels).

Free account
More of Ncardia with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ncardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Ncardia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View